Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C and depression

W R Yates1, O Gleason

  • 1Department of Psychiatry, University of Oklahoma Health Sciences Center, Tulsa, USA. william-yates@ouhsc.edu

Depression and Anxiety
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined internal medicine-psychiatry and family medicine-psychiatry training programs, 1999-2000: program directors' perspectives.

Academic medicine : journal of the Association of American Medical Colleges·2001
Same author

Tramadol dependence with no history of substance abuse.

The American journal of psychiatry·2001
Same author

Improving return rates for health-care outcome.

Psychological reports·2000
Same author

Psychiatric effects of anabolic steroids after burn injuries.

Psychosomatics·2000
Same author

Five cases of interferon-alpha-induced depression treated with antidepressant therapy.

Psychosomatics·1999
Same author

Childhood trichotillomania. Successful treatment with fluoxetine following an SSRI failure.

Psychosomatics·1999
Same journal

Systematic Review and Exploratory Meta-Analysis of AI-Enabled and Digital Technology-Assisted Interventions for Dental Anxiety During Dental Treatment.

Depression and anxiety·2026
Same journal

Measurement of Serum Parameters Attributes the Therapeutic Effects of Music Therapy to Augmented Stress-Coping Ability and Diminished Systemic Inflammation.

Depression and anxiety·2026
Same journal

Differential Patterns of Social Attention and Memory Profiles in Depression: Evidence From Third-Person Social Interaction Processing.

Depression and anxiety·2026
Same journal

Associations Between Adverse Childhood Experiences and Prenatal Depression Mediated Through Family Communication in Chinese Pregnant Women: Causal Mediation Analysis.

Depression and anxiety·2026
Same journal

How Does Fertility Stress Influence Depressive Symptoms in Female Partners of Infertile Couples in China? A Parallel Mediation Analysis of Infertility Stigma and Family Function.

Depression and anxiety·2026
Same journal

Network and Factor Structure of Depression and Anxiety Symptoms in Telemental Healthcare Patients From Bangladesh: Evidence for Precision Mental Healthcare.

Depression and anxiety·2026
See all related articles

Chronic hepatitis C (HCV) patients often experience mood disorders. Psychiatric intervention may help manage depression linked to HCV and its interferon treatment, requiring physician awareness.

Area of Science:

  • Hepatology
  • Psychiatry
  • Infectious Diseases

Background:

  • A significant population has chronic hepatitis C (HCV) despite declining incidence.
  • Asymptomatic HCV patients risk developing clinical symptoms within 15-20 years without effective antivirals.
  • Mood disorders are prevalent in HCV patients seeking psychiatric care.

Purpose of the Study:

  • To highlight the connection between hepatitis C virus infection and mood disorders.
  • To inform psychiatrists about the diagnostic and treatment challenges of depression in HCV patients.
  • To emphasize the potential benefits of psychiatric intervention for HCV-associated mood disturbances.

Main Methods:

  • Review of clinical observations and existing literature on hepatitis C and psychiatric comorbidities.

Related Experiment Videos

  • Analysis of mood disorder prevalence in HCV patients referred for psychiatric consultation.
  • Discussion of treatment implications, including interferon-induced neuropsychiatric effects.

    • Main Results:

    • Mood disorders are frequently observed in patients with chronic hepatitis C.
    • Interferon therapy, a primary HCV treatment, can precipitate depression and other neuropsychiatric syndromes.
    • Psychiatric interventions show potential for managing mood disorders in this population.

    Conclusions:

    • Hepatitis C virus infection is associated with a high incidence of mood disorders.
    • Psychiatrists must be vigilant in diagnosing and treating depression complicating chronic hepatitis C.
    • Effective psychiatric management can improve outcomes for HCV patients experiencing mood disturbances.